Abstract
OBJECTIVE: To assess the effects of BMI at baseline and on-treatment weight change on the lipid-lowering efficacy of diet plus fibric acid derivatives (fibrates) in hypercholesterolemic adults. SUBJECTS: 6003 participants in a Belgian General Practitioners Trial, an open-label, prospective study conducted in a primary care setting. MEASURES: Effect of initial BMI, on-treatment weight change, or lipid values at baseline on percentage changes in low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and triglycerides (TG). Multiple linear regression models, including initial BMI, on-treatment weight change, age, gender, and baseline lipid values, were fitted to control the influences exerted by these variables on each other. RESULTS: Reductions in LDL-C after diet plus fibrate treatment for 12 weeks were inversely related to initial BMI and to TG levels at baseline, and were positively associated with baseline LDL-C concentrations and with on-treatment weight change (P<0.001 for all analyses). Decreases in TG related negatively with initial BMI (P=0.012), and positively with weight loss (P=0.011) and TG at baseline (P<0.001). Increases in HDL-C were negatively associated with initial BMI (P=0.012) and with baseline TG (P<0.001). CONCLUSIONS: The LDL-C lowering efficacy of fibrates is inversely related to initial BMI, and is positively associated with on-treatment weight loss.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Muls, E., Van Gaal, L., Autier, P. et al. Effects of initial BMI and on-treatment weight change on the lipid-lowering efficacy of fibrates. Int J Obes 21, 155–158 (1997). https://doi.org/10.1038/sj.ijo.0800370
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0800370